Oxford Ledge
Search
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) is a biotechnology company trading at $1.54 (−1.9% today). Figures from SEC EDGAR and market feeds; updated 2026-07-15 03:58 UTC.
Acurx Pharmaceuticals is a biopharmaceutical company developing small molecule antibiotics to treat difficult-to-treat Gram-positive bacterial infections, including C. difficile, MRSA, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae. The company's approach targets DNA polymerase IIIC, a bacterial enzyme required for DNA replication in certain Gram-positive species, representing a previously unexploited scientific target.
Summarized from Acurx Pharmaceuticals, Inc.’s SEC filings · Read the filing ↗
| Quote | |
| Price | $1.54 |
| Change (1D) | -0.03 (-1.91%) |
| Volume | 72.4K shares |
| 52-week range | $1.33 – $21.00 |
| Returns | |
| 52-week return | +15.8% |
Acurx Pharmaceuticals is a biopharmaceutical company developing small molecule antibiotics to treat difficult-to-treat Gram-positive bacterial infections, including C.
ACXP trades at $1.54, as of 2026-07-15.
Acurx Pharmaceuticals, Inc.'s most recent SEC filing on record is a 10-Q filed 2026-05-11. All filings link to their SEC EDGAR originals above.
SEC EDGAR filings and public market data feeds, fetched 2026-07-15 03:58 UTC. This page is also available as JSON at /api/data?ticker=ACXP and is emitted with FAQPage structured data for machine reading.
Charts, 10-year financials, peer comparison, screening and portfolio tracking for ACXP and 3,500+ tickers.
Create a free account — keep ACXPGET /api/data?ticker=ACXP
This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt